Target intelligence / Profile preview

Dual adaptor of phosphotyrosine and 3-phosphoinositides 1 (DAPP1)

Target
DAPP1
Molecular classification
Adaptor protein, Pleckstrin homology (PH) domain-containing protein, Src homology 2 (SH2) domain-containing protein, Other
01

Overview

Dual adaptor of phosphotyrosine and 3-phosphoinositides 1 (DAPP1), also known as BAM32, is an adaptor protein expressed predominantly in B lymphocytes and other immune cells[1][2][4][6]. It contains an N-terminal Src homology 2 (SH2) domain and a C-terminal pleckstrin homology (PH) domain[4][5]. DAPP1 is rapidly recruited to the plasma membrane upon B cell receptor (BCR) engagement, where it is phosphorylated by Src-family kinases (such as Lyn) in a phosphatidylinositol 3-kinase (PI3K)-dependent manner[1][2][5]. DAPP1 serves as a scaffold that coordinates signaling complexes by binding 3-phosphoinositide lipids and interacting with proteins like phospholipase C gamma 2 (PLCγ2), promoting activation of pathways involved in cytoskeletal remodeling, receptor internalization, cell adhesion, and spreading[1][2][3][5][7]. It plays a critical role in BCR-mediated antigen presentation, efficient formation of immune synapses, and the generation of high-affinity antibody responses[1][3][7]. DAPP1 is also involved in regulating responses in neutrophils and dendritic cells and is required for reactive oxygen species production during inflammation[9]. There are no drugs or small molecules currently known to target DAPP1 directly.

Other names
Bam32B-cell adaptor molecule of 32 kDaB lymphocyte adaptor protein Bam32HSPC066hDAPP1
02

Biological functions

Signal transductionImmune responseCytoskeletal reorganizationCell adhesionAntigen presentationAntibody response regulation
03

Disease associations

InflammationImmune deficiency (by altered antibody response)Potential role in autoimmunity (due to its regulatory function in immune signaling)Other

Beyond the preview

Go deeper on Dual adaptor of phosphotyrosine and 3-phosphoinositides 1 (DAPP1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dual adaptor of phosphotyrosine and 3-phosphoinositides 1 (DAPP1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call